LDN Social Media
Get connected with us on social networks
Dana Keaton, ND - The scope of patient selection for LDN (2019 Conference) (LDN, low dose naltrexone)
Dana Keaton, ND discusses the inflammatory disorders calmed by LDN, including age-associated diseases of cancer, arthritis, diabetes, Alzheimer’s, and hypertension. She presents current anti-inflammatory agents used in immune dysregulation, and reasons to choose or not choose LDN over them. She also discusses a wellness path, and monitoring the effects of treatment